First National Trust Co Has $5.08 Million Stock Position in Aflac Incorporated $AFL

First National Trust Co lowered its position in Aflac Incorporated (NYSE:AFL) by 31.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 45,507 shares of the financial services provider’s stock after selling 21,023 shares during the period. First National Trust Co’s holdings in Aflac were worth $5,083,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. True Wealth Design LLC increased its stake in Aflac by 188.5% during the 3rd quarter. True Wealth Design LLC now owns 225 shares of the financial services provider’s stock valued at $25,000 after purchasing an additional 147 shares in the last quarter. Mid American Wealth Advisory Group Inc. acquired a new position in shares of Aflac during the second quarter valued at about $26,000. Whipplewood Advisors LLC increased its position in shares of Aflac by 1,526.7% during the second quarter. Whipplewood Advisors LLC now owns 244 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 229 shares in the last quarter. Chilton Capital Management LLC acquired a new stake in shares of Aflac in the 2nd quarter worth about $26,000. Finally, Darwin Wealth Management LLC bought a new position in Aflac in the 2nd quarter valued at about $33,000. Institutional investors own 67.44% of the company’s stock.

Analyst Ratings Changes

A number of analysts have commented on the company. JPMorgan Chase & Co. boosted their price objective on Aflac from $101.00 to $105.00 and gave the stock a “neutral” rating in a report on Monday, January 5th. Weiss Ratings reissued a “buy (b+)” rating on shares of Aflac in a research report on Monday, December 22nd. Wells Fargo & Company lifted their price objective on shares of Aflac from $107.00 to $109.00 and gave the stock an “equal weight” rating in a report on Friday, November 7th. Evercore increased their target price on shares of Aflac from $110.00 to $111.00 and gave the company an “underperform” rating in a report on Friday, November 7th. Finally, Morgan Stanley set a $120.00 price target on shares of Aflac in a research report on Monday, December 15th. Three analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, Aflac currently has a consensus rating of “Hold” and an average target price of $110.91.

Aflac Stock Performance

NYSE AFL opened at $113.30 on Tuesday. The company has a market capitalization of $59.38 billion, a PE ratio of 16.47, a price-to-earnings-growth ratio of 3.83 and a beta of 0.67. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.11 and a current ratio of 0.11. Aflac Incorporated has a 52-week low of $96.95 and a 52-week high of $119.32. The company has a 50-day simple moving average of $110.19 and a 200 day simple moving average of $108.81.

Aflac (NYSE:AFL) last released its earnings results on Wednesday, February 4th. The financial services provider reported $1.57 earnings per share for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.12). Aflac had a net margin of 21.24% and a return on equity of 14.35%. The company had revenue of $4.87 billion for the quarter, compared to the consensus estimate of $4.45 billion. During the same period in the prior year, the company earned $1.57 earnings per share. The firm’s revenue was down 9.6% on a year-over-year basis. On average, research analysts predict that Aflac Incorporated will post 6.88 EPS for the current year.

Insiders Place Their Bets

In other Aflac news, EVP Audrey B. Tillman sold 15,862 shares of the business’s stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $112.00, for a total value of $1,776,544.00. Following the sale, the executive vice president directly owned 230,688 shares in the company, valued at $25,837,056. The trade was a 6.43% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Joseph L. Moskowitz sold 786 shares of the company’s stock in a transaction on Monday, November 17th. The shares were sold at an average price of $113.75, for a total value of $89,407.50. Following the transaction, the director directly owned 24,829 shares in the company, valued at $2,824,298.75. This represents a 3.07% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 29,044 shares of company stock valued at $3,241,981 over the last ninety days. 0.80% of the stock is currently owned by insiders.

About Aflac

Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.

Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.